These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10211926)

  • 1. Does valproate pose a threat to human immunodeficiency virus-infected patients?
    Hardy MA; Nardacci D
    J Clin Psychopharmacol; 1999 Apr; 19(2):189-90. PubMed ID: 10211926
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
    Dasgupta A; McLemore JL
    Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible risks associated with valproate treatment of AIDS-related mania.
    Jefferson JW
    J Clin Psychiatry; 1998 Jun; 59(6):317. PubMed ID: 9671345
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid.
    Antoniou T; Gough K; Yoong D; Arbess G
    Clin Infect Dis; 2004 Mar; 38(5):e38-40. PubMed ID: 14986271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of valproic acid in HIV-positive patients.
    Jennings HR; Romanelli F
    Ann Pharmacother; 1999 Oct; 33(10):1113-6. PubMed ID: 10534224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate hepatotoxicity.
    Blaw ME; Belknap WM
    Pediatr Neurol; 1985; 1(5):320. PubMed ID: 3939748
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproate and spina bifida.
    Lancet; 1989 Mar; 1(8638):611-2. PubMed ID: 2564127
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC
    Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study.
    Cysique LA; Maruff P; Brew BJ
    BMC Neurol; 2006 Dec; 6():42. PubMed ID: 17150108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV agents. Can valproic acid help flush HIV from hiding?
    TreatmentUpdate; 2005; 17(6):4-5. PubMed ID: 17228475
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Valproate and pregnancy].
    Sabers A
    Ugeskr Laeger; 2011 Mar; 173(10):743. PubMed ID: 21375998
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium valproate and measles virus replication.
    Eugenio KR
    Eur J Pediatr; 2003 Mar; 162(3):195. PubMed ID: 12655427
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate and spina bifida.
    Oakeshott P; Hunt GM
    BMJ; 1989 May; 298(6683):1300-1. PubMed ID: 2500206
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased serum carnitine in valproate induced Reye syndrome.
    Böhles H; Richter K; Wagner-Thiessen E; Schäfer H
    Eur J Pediatr; 1982 Nov; 139(3):185-6. PubMed ID: 6819143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate in pregnancy linked to autism in children.
    BMJ; 2013 Apr; 346():f2602. PubMed ID: 23616359
    [No Abstract]   [Full Text] [Related]  

  • 17. No change to HIV-1 latency with valproate therapy.
    Steel A; Clark S; Teo I; Shaunak S; Nelson M; Gazzard B; Kelleher P
    AIDS; 2006 Aug; 20(12):1681-2. PubMed ID: 16868456
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of seizures in children infected with human immunodeficiency virus.
    Samia P; Petersen R; Walker KG; Eley B; Wilmshurst JM
    J Child Neurol; 2013 Mar; 28(3):297-302. PubMed ID: 22752475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
    Pantelis C; Adesanya A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
    [No Abstract]   [Full Text] [Related]  

  • 20. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.